Analyst Consensus ?
ConsensusBuy45 ratings
Bullish3680.0%
Neutral715.6%
Bearish24.4%
MongoDB, Inc. · MDB · FY2026 Q1 · Calendar Q2 2025
MongoDB: Atlas growth, margin gains and AI investment strengthen outlook
The current analysis supports a constructive but conditional view: Atlas consumption growth, improved operating leverage, AI product expansion and up-market execution strengthen MongoDB’s growth case. The thesis remains exposed to non-Atlas revenue pressure, competition and the pace of AI adoption.
Reported After market closeNASDAQTechnology
$27.15B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.00
Consensus $0.67
EPS surprise
+49.7%
Reported versus consensus
Reported revenue
$549.0M
Consensus $528.1M
Revenue surprise
+4.0%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+12.8%
Event window
SPY move
-0.5%
Same window
Abnormal move
+13.3%
Stock minus SPY
Volume
5.2×
Versus trailing sessions
Subsequent drift
-6.8%
Up to 20 sessions
MDBSPY benchmark
Ask FN2 about MDB FY2026 Q1
Transcript, numbers and history already loaded
Why did MDB rise 12.8% after beating EPS estimates in FY2026 Q1?What changed in MDB's guidance and outlook in FY2026 Q1?Give me the bull and bear case for MDB after FY2026 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, management’s stance strengthened: guidance sentiment moved from maintained to raised, non-GAAP operating margin improved to 16%, Atlas reached 72% of revenue, and the authorized buyback increased to $1 billion. The company also highlighted Voyage AI embedding and vector-search capabilities as a larger part of its product strategy.
Guidance delta
Management raised full-year revenue and margin guidance; the analysis does not provide the revised figures.
Key takeaways
- Revenue and Atlas growth beat guidance, with Atlas at 72% of total revenue.
- Non-GAAP operating margin reached 16%, and full-year margin guidance was raised by 200 basis points.
- Voyage AI and new embedding models are central to the company’s AI and vector-search strategy.
- Management expanded total authorized share repurchases to $1 billion and reported strong customer additions.
Management priorities
- Expand Atlas AI and vector-search capabilities, including automatic embedding generation.
- Scale application-modernization tools for legacy migrations.
- Pursue enterprise up-market growth and expand the self-serve channel.
- Continue developer education and product enhancements, including MongoDB 8.1.
Follow MDB with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$337.57Current
$215Low
$411.33Average
$560High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 17, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Needham | Buy | Buy | Maintain | Oct 13, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Oct 8, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Oct 2, 2026 |
| DA Davidson | Buy | Buy | Maintain | Oct 1, 2026 |
| UBS | Neutral | Neutral | Maintain | Sep 30, 2026 |
| Stifel | Buy | Buy | Maintain | Sep 30, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Sep 30, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Sep 30, 2026 |
| Macquarie | Neutral | Neutral | Maintain | Sep 30, 2026 |
| Guggenheim | Buy | Buy | Maintain | Sep 30, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Sep 30, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Sep 30, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Sep 30, 2026 |
| Rosenblatt | Buy | Buy | Maintain | Sep 2, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Sep 2, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Sep 2, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Sep 2, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Sep 2, 2026 |
| Citigroup | Buy | Buy | Maintain | Sep 2, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Sep 2, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Sep 2, 2026 |
| Barclays | Overweight | Overweight | Maintain | Sep 2, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 25, 2026 |
| Baird | Neutral | Neutral | Maintain | Aug 25, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 20, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 12, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jun 8, 2026 |
| Tigress Financial | Buy | Buy | Maintain | Jun 2, 2026 |
| Wedbush | Outperform | Outperform | Maintain | May 29, 2026 |
| Argus Research | Buy | Buy | Maintain | Dec 4, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Sep 19, 2025 |
| Wolfe Research | Outperform | Outperform | Maintain | Aug 27, 2025 |
| Monness, Crespi, Hardt | Buy | Neutral | Upgrade | Jun 5, 2025 |
| Loop Capital | Hold | Buy | Downgrade | May 20, 2025 |
| Keybanc | Overweight | Overweight | Maintain | Dec 10, 2024 |
| Redburn Atlantic | Sell | Neutral | Downgrade | Mar 19, 2024 |
| Capital One | Overweight | Equal Weight | Upgrade | Nov 8, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Mar 10, 2023 |
| Redburn Partners | Neutral | Sell | Upgrade | Oct 18, 2022 |
| Nomura | Reduce | Reduce | Maintain | Dec 10, 2019 |
| Piper Jaffray | Overweight | Overweight | Maintain | Oct 29, 2019 |
| Citi | Buy | Buy | Maintain | Sep 5, 2019 |
| Compass Point | Neutral | Neutral | Maintain | Aug 13, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jun 19, 2019 |
| Monness Crespi Hardt | Buy | Buy | Maintain | Apr 11, 2018 |
Named analyst price targets
Upside is calculated against the persisted current price $337.57. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Scotiabank | Patrick Colville | $450 | $366.23 | +33.3% | Oct 8, 2026 |
| D.A. Davidson | Rudy Kessinger | $415 | $353.36 | +22.9% | Sep 30, 2026 |
| Stifel Nicolaus | Brad Reback | $385 | $358.36 | +14.1% | Sep 30, 2026 |
| Piper Sandler | Hannah Rudoff | $470 | $356.22 | +39.2% | Sep 30, 2026 |
| BMO Capital | Analyst unavailable | $420 | $337.19 | +24.4% | Sep 30, 2026 |
| Mizuho Securities | Siti Panigrahi | $460 | $334.68 | +36.3% | Sep 29, 2026 |
| Monness | Brian White | $500 | $390.27 | +48.1% | Sep 2, 2026 |
| Stifel Nicolaus | Brad Reback | $465 | $389.85 | +37.7% | Sep 2, 2026 |
| UBS | Karl Keirstead | $410 | $380.95 | +21.5% | Sep 2, 2026 |
| Bernstein | Firoz Valliji | $484 | $380.5 | +43.4% | Sep 2, 2026 |
| RBC Capital | Rishi Jaluria | $465 | $390.89 | +37.7% | Sep 2, 2026 |
| Rosenblatt Securities | Blair Abernathy | $445 | $434.21 | +31.8% | Sep 2, 2026 |
| Canaccord Genuity | David Hynes | $480 | $434.21 | +42.2% | Sep 2, 2026 |
| Morgan Stanley | Sanjit Singh | $430 | $434.21 | +27.4% | Sep 2, 2026 |
| Morgan Stanley | Analyst unavailable | $519 | $434.21 | +53.7% | Sep 2, 2026 |
| Cantor Fitzgerald | Thomas Blakey | $540 | $446.57 | +60.0% | Aug 31, 2026 |
| Monness | Brian White | $460 | $444.84 | +36.3% | Aug 31, 2026 |
| UBS | Karl Keirstead | $460 | $405.28 | +36.3% | Aug 24, 2026 |
| Evercore ISI | Analyst unavailable | $525 | $420.37 | +55.5% | Aug 21, 2026 |
| Goldman Sachs | Matthew Martino | $453 | $434.62 | +34.2% | Aug 19, 2026 |
| Stifel Nicolaus | Brad Reback | $475 | $443.23 | +40.7% | Aug 18, 2026 |
| Guggenheim | Howard Ma | $560 | $438.7 | +65.9% | Aug 18, 2026 |
| KGI Securities | Analyst unavailable | $470 | $354.22 | +39.2% | Jul 8, 2026 |
| Tigress Financial | Ivan Feinseth | $515 | $398.54 | +52.6% | Jun 2, 2026 |
| Stifel Nicolaus | Brad Reback | $435 | $319.82 | +28.9% | May 29, 2026 |
| Needham | Mike Cikos | $400 | $325.68 | +18.5% | May 29, 2026 |
| UBS | Analyst unavailable | $366 | $325.68 | +8.4% | May 29, 2026 |
| Macquarie | Steve Koenig | $315 | $325.68 | -6.7% | May 29, 2026 |
| Morgan Stanley | Sanjit Singh | $380 | $325.68 | +12.6% | May 29, 2026 |
| Cantor Fitzgerald | Thomas Blakey | $416 | $326.13 | +23.2% | May 26, 2026 |
| Wedbush | Daniel Ives | $380 | $258.97 | +12.6% | Mar 3, 2026 |
| Needham | Mike Cikos | $300 | $325.01 | -11.1% | Mar 3, 2026 |
| BMO Capital | Keith Bachman | $340 | $325.01 | +0.7% | Mar 3, 2026 |
| D.A. Davidson | Rudy Kessinger | $385 | $312.66 | +14.1% | Feb 25, 2026 |
| RBC Capital | Analyst unavailable | $500 | $389.2 | +48.1% | Jan 15, 2026 |
| Goldman Sachs | Matthew Martino | $475 | $399.65 | +40.7% | Jan 5, 2026 |
| D.A. Davidson | Rudy Kessinger | $465 | $405.54 | +37.7% | Dec 2, 2025 |
| Piper Sandler | Hannah Rudoff | $490 | $406.64 | +45.2% | Dec 2, 2025 |
| Oppenheimer | Ittai Kidron | $450 | $405.94 | +33.3% | Dec 2, 2025 |
| Bernstein | Firoz Valliji | $452 | $407.34 | +33.9% | Dec 2, 2025 |
| Stifel Nicolaus | Brad Reback | $375 | $352.99 | +11.1% | Nov 4, 2025 |
| BMO Capital | Keith Bachman | $415 | $353.02 | +22.9% | Nov 4, 2025 |
| RBC Capital | Rishi Jaluria | $405 | $352.48 | +20.0% | Nov 4, 2025 |
| Truist Financial | Miller Jump | $400 | $369.05 | +18.5% | Nov 3, 2025 |
| Wells Fargo | Ryan MacWilliams | $430 | $310.38 | +27.4% | Sep 30, 2025 |
| Scotiabank | Patrick Colville | $160 | $173.5 | -52.6% | Apr 25, 2025 |
| Wells Fargo | Analyst unavailable | $225 | $192.98 | -33.3% | Mar 6, 2025 |
| Cantor Fitzgerald | Thomas Blakey | $344 | $251.99 | +1.9% | Mar 5, 2025 |
| UBS | Blair Abernethy | $350 | $254.38 | +3.7% | Mar 4, 2025 |
| Loop Capital Markets | Yun Kim | $400 | $322.4 | +18.5% | Dec 2, 2024 |
| Goldman Sachs | Kash Rangan | $340 | $290.79 | +0.7% | Aug 30, 2024 |
| Morgan Stanley | Sanjit Singh | $340 | $282.42 | +0.7% | Aug 30, 2024 |
| Truist Financial | Miller Jump | $320 | $245.72 | -5.2% | Aug 30, 2024 |
| KeyBanc | Eric Heath | $278 | $220.09 | -17.6% | Jun 13, 2024 |
| Scotiabank | Patrick Colville | $250 | $236.06 | -25.9% | Jun 3, 2024 |
| Stifel Nicolaus | Brad Reback | $300 | $310 | -11.1% | May 31, 2024 |
| Oppenheimer | Ittai Kidron | $300 | $310 | -11.1% | May 31, 2024 |
| Loop Capital Markets | Yun Kim | $315 | $310 | -6.7% | May 31, 2024 |
| Piper Sandler | Brent Bracelin | $290 | $310 | -14.1% | May 31, 2024 |
| Piper Sandler | Brent Bracelin | $350 | $310 | +3.7% | May 31, 2024 |
| Robert W. Baird | William Power | $305 | $310 | -9.6% | May 31, 2024 |
| Canaccord Genuity | David Hynes | $325 | $310 | -3.7% | May 31, 2024 |
| Morgan Stanley | Sanjit Singh | $320 | $310 | -5.2% | May 31, 2024 |
| Mizuho Securities | Matthew Broome | $250 | $310 | -25.9% | May 31, 2024 |
| Truist Financial | Miller Jump | $300 | $310 | -11.1% | May 31, 2024 |
| Barclays | Raimo Lenschow | $290 | $310 | -14.1% | May 31, 2024 |
| Wells Fargo | Andrrew Nowinski | $450 | $335.86 | +33.3% | May 29, 2024 |
| Loop Capital Markets | Yun Kim | $415 | $340.16 | +22.9% | Apr 22, 2024 |
| D.A. Davidson | Rudy Kessinger | $430 | $384.84 | +27.4% | Mar 8, 2024 |
| Truist Financial | Miller Jump | $500 | $407.16 | +48.1% | Mar 7, 2024 |
| Oppenheimer | Ittai Kidron | $480 | $387.42 | +42.2% | Dec 6, 2023 |
| Truist Financial | Miller Jump | $420 | $393.14 | +24.4% | Jun 23, 2023 |
| Needham | Mike Cikos | $430 | $373.14 | +27.4% | Jun 2, 2023 |
| RBC Capital | Rishi Jaluria | $235 | $209.76 | -30.4% | Mar 9, 2023 |
| Needham | Mike Cikos | $205.93 | $211.09 | -39.0% | Mar 9, 2023 |
| Bernstein | Firoz Valliji | $282 | $210.66 | -16.5% | Feb 17, 2023 |
| Needham | Needham Needham | $240 | $196.84 | -28.9% | Jan 2, 2023 |
| Piper Sandler | Brent Bracelin | $270 | $175.96 | -20.0% | Dec 7, 2022 |
| JMP Securities | Patrick Walravens | $215 | $144.69 | -36.3% | Dec 7, 2022 |
| Barclays | Raimo Lenschow | $360 | $244.12 | +6.6% | Sep 1, 2022 |
| Mizuho Securities | Matthew Broome | $300 | $322.86 | -11.1% | Sep 1, 2022 |
| Needham | Mike Cikos | $330 | $322.86 | -2.2% | Sep 1, 2022 |
| RBC Capital | Rishi Jaluria | $350 | $322.86 | +3.7% | Sep 1, 2022 |
| RBC Capital | Rishi Jaluria | $350 | $322.86 | +3.7% | Sep 1, 2022 |
| RBC Capital | Rishi Jaluria | $375 | $249.75 | +11.1% | Jun 17, 2022 |
| Piper Sandler | Brent Bracelin | $430 | $241.81 | +27.4% | Jun 2, 2022 |
| Goldman Sachs | Kash Rangan | $435 | $286.7 | +28.9% | Jun 2, 2022 |
| Morgan Stanley | Sanjit Singh | $368 | $286.7 | +9.0% | Jun 2, 2022 |
| Mizuho Securities | Matthew Broome | $270 | $241.81 | -20.0% | Jun 2, 2022 |
| Mizuho Securities | Matthew Broome | $270 | $286.7 | -20.0% | Jun 2, 2022 |
| Needham | Mike Cikos | $310 | $286.7 | -8.2% | Jun 2, 2022 |
| RBC Capital | Rishi Jaluria | $325 | $286.7 | -3.7% | Jun 2, 2022 |
| Citigroup | Tyler Radke | $405 | $237.15 | +20.0% | May 31, 2022 |
| Morgan Stanley | Sanjit Singh | $378 | $248.1 | +12.0% | May 23, 2022 |
| Barclays | Raimo Lenschow | $330 | $248.1 | -2.2% | May 21, 2022 |
| Mizuho Securities | Matthew Broome | $270 | $245.33 | -20.0% | May 20, 2022 |
| UBS | Karl Keirstead | $450 | $390.5 | +33.3% | Mar 21, 2022 |
| Citigroup | Tyler Radke | $525 | $334.09 | +55.5% | Mar 9, 2022 |
| Needham | Mike Cikos | $362 | $334.09 | +7.2% | Mar 9, 2022 |
| Mizuho Securities | Matthew Broome | $325 | $334.09 | -3.7% | Mar 9, 2022 |
| RBC Capital | Rishi Jaluria | $505 | $281.74 | +49.6% | Mar 8, 2022 |
| Mizuho Securities | Matthew Broome | $400 | $390.18 | +18.5% | Feb 21, 2022 |
| Tigress Financial | Ivan Feinseth | $630 | $427.17 | +86.6% | Feb 11, 2022 |
| Barclays | Raimo Lenschow | $556 | $396.89 | +64.7% | Jan 17, 2022 |
| Macquarie | Frederick Havemeyer | $552 | $499.82 | +63.5% | Dec 7, 2021 |
| Piper Sandler | Brent Bracelin | $585 | $499.82 | +73.3% | Dec 7, 2021 |
| Argus Research | Joseph Bonner | $550 | $489.75 | +62.9% | Sep 7, 2021 |
| SMBC Nikko | Steven Koenig | $393 | $365.57 | +16.4% | Jul 6, 2021 |
Track every rating change on MDB the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationMongoDB, Inc. serves as a global provider of a versatile database platform. The company's offerings feature MongoDB Enterprise Advanced, a sophisticated commercial database server designed for corporate clients, which can be deployed in cloud, on-premises, or hybrid environments. It also presents MongoDB Atlas, a fully managed, multi-cloud database-as-a-service (DBaaS) solution. For developers seeking to start with MongoDB, the company offers a free, downloadable Community Server that includes fundamental database functionalities. Beyond its core database products, MongoDB, Inc. provides professional services such as consulting and training. Founded in 2007 and based in New York, New York, the company was formerly known as 10gen, Inc. before adopting the name MongoDB, Inc. in August 2013.
Historical context
All MDB earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| WIT Wipro Limited | FY2027 Q2 · Calendar Q4 2026 | -25.0% | +3.9% | Wipro: AI pipeline expands as Q3 guidance stays narrow |
| TSM Taiwan Semiconductor Manufacturing Company Limited | FY2026 Q3 · Calendar Q4 2026 | +3.4% | -1.8% | TSMC beats Q3 guidance as AI demand drives fab expansion |
| ERIC Telefonaktiebolaget LM Ericsson (publ) | FY2026 Q3 · Calendar Q4 2026 | +28.6% | +11.8% | Ericsson Q3: 7% organic growth, resilient margins and AI-led demand |
| ASML ASML Holding N.V. | FY2026 Q3 · Calendar Q4 2026 | +20.4% | -3.9% | ASML: Record Q3, strong AI demand and broader capacity plans |
Latest beats and misses
Who reports nextBeat on EPS
Get the MDB recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:55.686058+00:00
- Polygon adjusted daily market bars · 2026-10-17T17:30:44.812342+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-17T17:30:44.809348+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-17. For educational purposes only; not investment advice.